Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01568749 · ClinicalTrials.gov registry record · Phase 1
A Study Investigating the Pharmacokinetic Profiles of Four Extended Release Paracetamol Formulations
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT01568749 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 14 participants.
The verdict
NCT01568749, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
A study investigating the pharmacokinetic profiles of four extended release paracetamol formulations
Interventions
- DRUG Paracetamol
- DRUG Paracetamol formulation 1
- DRUG Paracetamol Formulation 2
- DRUG Paracetamol formulation 3
- DRUG Paracetamol formulation 4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01568749
The ClinicalTrials.gov registry entry for NCT01568749 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Paracetamol is the first listed.
NCT01568749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01568749 about?
NCT01568749 is a clinical study titled "A Study Investigating the Pharmacokinetic Profiles of Four Extended Release Paracetamol Formulations". A study investigating the pharmacokinetic profiles of four extended release paracetamol formulations
What is the current status of trial NCT01568749?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2008-12. Estimated completion is 2009-08.
What interventions are being tested in trial NCT01568749?
The interventions under investigation include: Paracetamol (DRUG), Paracetamol formulation 1 (DRUG), Paracetamol Formulation 2 (DRUG), Paracetamol formulation 3 (DRUG), Paracetamol formulation 4 (DRUG).
Who is sponsoring clinical trial NCT01568749?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.